Tag: pediatric exclusivity
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
18 Dec 2025
Generic Drug Quality Issues: Manufacturing Plant Problems Explained
-
7 Dec 2025
National Prescription Drug Take-Back Days: What to Expect
-
30 Dec 2025
Desensitization Protocols for Medication Side Effects: When They’re Used
-
1 Oct 2025
How Targeted Therapy Is Changing Cancer Treatment
-
3 Oct 2025
Tadarise vs Cialis, Viagra & Other ED Drugs: Full Comparison